References
- Middleton PG, Taylor PR, Jackson G, et al. Cytokine gene polymorphisms associating with severe acute graft-versus-host disease in HLA-identical sibling transplants. Blood. 1998;92:3943–3948.
- Socié G, Loiseau P, Tamouza R, et al. Both genetic and clinical factors predict the development of graft-versus-host disease after allogeneic hematopoietic stem cell transplantation. Transplantation. 2001;72:699–706.
- Rocha V, Franco RF, Porcher R, et al. Host defense and inflammatory gene polymorphisms are associated with outcomes after HLA-identical sibling bone marrow transplantation. Blood. 2002;100:3908–3918.
- Kielsen K, Enevold C, Heilmann C, et al. Donor Genotype in the Interleukin-7 receptor α-Chain predicts risk of Graft-versus-Host disease and cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation. Front. Immunol [Internet]. 2018; [cited 2019 Mar 25]. Available from: http://journal.frontiersin.org/article/10.3389/fimmu.2018.00109/full
- Santos N, Rodríguez-Romanos R, de la Cámara R, et al. On behalf of the GvHD/Immunotherapy Working Party of the Spanish Group of Hematopoietic Transplant (GETH). PD-1 genotype of the donor is associated with acute graft-versus-host disease after HLA-identical sibling donor stem cell transplantation. Ann Hematol. 2018;97:2217–2224.
- Hammrich J, Wittig S, Ernst T, et al. CTLA-4 polymorphism rs231775: Influence on relapse and survival after allogeneic hematopoietic stem cell transplantation in childhood. Eur J Haematol. 2019;102:251–255.
- Rocha V, Porcher R, Fernandes JF, et al. Association of drug metabolism gene polymorphisms with toxicities, graft-versus-host disease and survival after HLA-identical sibling hematopoietic stem cell transplantation for patients with leukemia. Leukemia. 2009;23:545–556.
- Ugai T, Kanda Y, Morishima Y, et al. Role of genetic polymorphism of ALDH2 in hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 2017;23:1374–1380.
- Ock C-Y, Seo H, Kim D-Y, et al. Discovery of donor genotype associated with long-term survival of patients with hematopoietic stem cell transplantation in refractory acute myeloid leukemia. Leuk Lymphoma. 2018;3;1–7.
- Karaesmen E, Rizvi AA, Preus LM, et al. Replication and validation of genetic polymorphisms associated with survival after allogeneic blood or marrow transplant. Blood. 2017;130:1585–1596.
- Zhu Q, Yan L, Liu Q, et al. Exome chip analyses identify genes affecting mortality after HLA-matched unrelated-donor blood and marrow transplantation. Blood. 2018;131:2490–2499.
- Boudreau JE, Giglio F, Gooley TA, et al. KIR3DL1/HL A-B subtypes govern acute myelogenous leukemia relapse after hematopoietic cell transplantation. JCO. 2017;35:2268–2278.